Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression

Developmental Immunology

Volumn 7, Issue 2-4, 2000, Pages 77-88

  Zakirov, Ravil Z ^a,b   Pavlov, Alexander V ^a   Vasilakos, Athanasios ^c  

^a VAVILOV STATE OPTICAL INSTITUTE   (Russian Federation)

^b State Institute for Fine Mechanics and Optics   (Russian Federation)

^c INSTITUTE OF COMPUTER SCIENCE   (Greece)

Author keywords

Human lymphoid tumors; Matrix degrading enzymes; Multiple myeloma; Mycosis fungoides; Proteolysis; Tumor progression

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ADVANCED CANCER; ARTICLE; B CELL LEUKEMIA; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; LYMPHATIC SYSTEM TUMOR; METASTASIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T CELL LEUKEMIA;

HUMANS; JURKAT CELLS; LEUKEMIA, B-CELL; LEUKEMIA, T-CELL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; PLASMA CELLS; RNA, MESSENGER;

EID: 0033769087     PISSN: 10446672     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/74372     Document Type: Article

References (40)

1. A rapid in vitro assay for quantitating the invasive potential of tumor cells
2. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production
3. Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells
4. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to malignant plasma cell
5. Matrix metalloproteinase inhibitors in arthritis
6. Membrane-type 2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
7. Matrix metalloproteinases and the development of cancer
8. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes
9. Angiogenesis in cancer, vascular, rheumatoid and other disease
10. New perspectives in clinical oncology from angiogenic research
11. Metalloproteinase inhibition as therapeutics
12. The role of metalloproteinases and their inhibitors in hematologic disorders
13. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kDa enzyme genes in HT-1080 cells
14. Matrix metalloproteinases
15. Prognostic values of matrix metalloproteinase-2 expression in bladder cancer
16. Cytokine, cytokine receptors, transduction signals and oncogenes in multiple myeloma
17. A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia
18. Proteolytic activity of human non-Hodgkin's lymphoma
19. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans
20. Clinical importance of metalloproteinases and their inhibitors
21. The role of macrophages in tumor angiogenesis
22. Expression of several matrix metalloproteinase genes in human monocytic cells
23. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration
24. Matrix metalloproteinases: Structures, evolution and diversification
25. Cytokines involved in the progression of multiple myeloma
26. Biology and biochemistry of proteinases in tumor invasion
27. Fibrinolytic and inflammatory process in pleural effusions
28. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
29. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
30. Regulation of 92 kD gelatinase release in HL-60 leukemia cells: Tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion
31. Matrix metalloproteinase and angiogenesis: A moving target for therapeutic intervention
32. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells
33. Human B lymphocytes synthesize the 92 kDa type IV gelatinase, matrix metalloproteinase-9
34. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinase-2 and -9
35. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis and angiogenesis
36. Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
37. Regulation of host-mediated anti-tumor mechanisms of cytokines. Direct and indirect effects on leukocyte recruitment and angiogenesis
38. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B)
39. Tumoral vascularity as a prognostic factor in cancer patients: The evidence continues to grow
40. Classification of primary cutaneous T-cell lymphomas